| | | | | |
AGIO Agios Pharmaceuticals, Inc. | €24,7825 | +3,97% | €1,50B | €558,13K | |
SGRY Surgery Partners, Inc. Common Stock | €11,7755 | +1,22% | €1,50B | €1,32M | |
GAB The Gabelli Equity Trust Inc. | €4,8222 | -0,18% | €1,50B | €1,09M | |
HURN Huron Consulting Group Inc. | €92,3788 | +2,36% | €1,49B | €114,79K | |
ENVX Enovix Corporation Common Stock | €7,1988 | +1,58% | €1,49B | €6,24M | |
PAYO Payoneer Global Inc. Common Stock | €4,4174 | +0,79% | €1,49B | €5,61M | |
ETV Eaton Vance Tax-Managed Buy-Write Opportunities Fund | €12,8562 | +0,13% | €1,49B | €149,87K | |
STGW Stagwell Inc. Class A Common Stock | €5,7608 | +1,52% | €1,49B | €830,69K | |
CASH Pathward Financial, Inc. Common Stock | €68,0570 | +1,67% | €1,49B | €255,58K | |
SNDX Syndax Pharmaceuticals, Inc. | €15,5170 | -1,74% | €1,49B | €6,71M | |
STRA Strategic Education, Inc. Common Stock | €69,2755 | +1,77% | €1,49B | €192,18K | |
CAPR Capricor Therapeutics Inc | €24,0419 | +1,01% | €1,49B | €503,05K | |
AAPG Ascentage Pharma Group International American Depository Shares | €15,3491 | -0,25% | €1,49B | €4,19K | |
SLS SELLAS Life Sciences Group, Inc. Common Stock | €7,7843 | +10,38% | €1,49B | €7,20M | |
PLSE Pulse Biosciences, Inc Common Stock (DE) | €23,1851 | +7,74% | €1,48B | €551,66K | |
